Skip to content

Use of Tab Pcosta With Tab PCOS Herb In Aartavkshay(Polycystic Ovarian Syndrome)

Open Randomised Control Clinical Trial Of Tab Pcosta (Formulation Of Tamrabhasma With Nirgundi Beejchurna,Kumari Ghanasar,Shunthi Churna,Dalchinichurna) With Tab PCOS Herb(Formulation Of Nirgundi Beejchurna Churna,Kumari Ghanasar,Shunthi Churna,Dalchini Churna) In Aartavkshay With Special Reference To Polycystic Ovarian Syndrome - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093007
Enrollment
66
Registered
2025-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Sponsors

Dr Bhagyashree Babasaheb Pawar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of age group 18-35 years irrespective of marital status. 2. .known cases of PCOS. 3. Patient fulfilling:-Rotterdam criteria:-(ESHRE/ASRM 2003) requires any of two of the following three criteria for the diagnosis of PCOS. Oligomenorrhoea or amenorrhoea Hyperandrogenism-clinical and biochemical. USG suggestive of.

Exclusion criteria

Exclusion criteria: 1 Patient diagnose with Fibroid Adenomyosis Endometriosis 2 Anemia:HB less than 7mg Diabetes Mellitus 3 Lactating mother 4 Pittapradhan Prakruti 5 Pregnant women

Design outcomes

Primary

MeasureTime frame
Regimen of Tab P-COSTA with Tab P-COS HERB is effective in AartavkshayTimepoint: 180 days

Secondary

MeasureTime frame
Tab Ovral-L (OC pills) is more effective in AartavkshayTimepoint: 180 days

Countries

India

Contacts

Public ContactDr Radha Phadnis

Hon Shri Annasaheb Dange Ayurved Medica College Post Graduate and Research Center Ashta

radhakulkarni6@gmail.com9545114545

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026